Riskpilot← Back to searchSign inGet full accessFL Medical AB
ABActiveOrg 5568786833Malmavägen 4Hospital activities · NACE 8610Est. 20110 employees
Revenue 2024
SEK 737K
+45% vs 2023
EBITDA margin
92.4%
+74% vs 2023
Equity ratio
74.9%
Financial strength
Net profit 2024
SEK 580K
+93% vs 2023
| Revenue | SEK 737K | +45% |
| EBITDA | SEK 681K | +74% |
| Net profit | SEK 580K | +93% |
| Total assets | SEK 1,8M | +49% |
| Equity | SEK 1,4M | +73% |
| Employees | 0 | — |
Legal name
FL Medical AB
Org number
5568786833
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
27 december 2011
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsultverksamhet inom hälso- och sjukvård, undervisning inom medicin samt läkarpraktik samt därmed förenlig verksamhet. Utöver det ska bolaget också bedriva konsultverksamhet inom management, organisation och ledarskap företrädesvis inom hälso- och sjukvård samt därmed förenlig verksamhet. Bolaget ska även äga och förvalta egendom och värdepapper samt därmed förenlig verksamhet.
Address
Malmavägen 4
Email
fredrik@flmedical.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 56 | 286 | 510 | 737 |
| Staff expenses | — | — | −7 | −72 | −15 |
| EBITDA | −13 | 22 | 245 | 392 | 681 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −13 | 22 | 245 | 392 | 681 |
| Net financials | — | — | 1 | −9 | 43 |
| Profit before tax | −13 | 22 | 245 | 383 | 724 |
| Tax | −0 | −0 | −49 | −84 | −145 |
| Net profit | −13 | 22 | 196 | 300 | 580 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 481 | 510 | 801 | 1 238 | 1 839 |
| Equity | 279 | 301 | 497 | 797 | 1 377 |
| Long-term debt | 187 | 187 | 194 | 201 | 120 |
| Short-term debt | 15 | 22 | 109 | 239 | 342 |
| Total debt | 202 | 209 | 303 | 441 | 462 |
EBITDA margin
92.4%
This company
15.8%
Market median
+485% vs market
20202024
Equity ratio
74.9%
This company
38.2%
Market median
+96% vs market
20202024
Return on equity
42.1%
This company
18.4%
Market median
+129% vs market
20202024
Net profit margin
78.7%
This company
8.1%
Market median
+872% vs market
20202024
Asset turnover
0.40×
This company
1.12×
Market median
-64% vs market
20202024
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
AM Auditor Substitute | Auditor Substitute | 2022 |
LF Chief Executive Officer | Chief Executive Officer | 2022 |
LE | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FL Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anne Marie Svedare | Auditor Substitute | 0 companies |
| Lars Fredrik Lennmyr | Chief Executive Officer | 0 companies |
| Lena Elisabeth Lindgren | Audit | 0 companies |
| Lars-Erik Lennmyr | Deputy Board Member | 0 companies |